DMH4

Term ID

CHEBI:229963

Synonyms

3-phenyl-6-[4-(2-morpholinoethoxy)phenyl]pyrazolo[1,5-a]pyrimidine
6-[4-[2-(4-morpholinyl)ethoxy]phenyl]-3-phenyl-pyrazolo[1,5-a]pyrimidine
6-{4-[2-(morpholin-4-yl)ethoxy]phenyl}-3-phenylpyrazolo[1,5-a]pyrimidine
DMH 4

Definition

A pyrazolopyrimidine that is pyrazolo[1,5-a]pyrimidine substituted by phenyl and 4-[2-(morpholin-4-yl)ethoxy]phenyl groups at positions 3 and 6, respectively. It is an inhibitor of VEGFR-2 (IC50 = 0.16 muM).

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: aromatic ether benzenes morpholines pyrazolopyrimidine tertiary amino compound

aromatic ether benzenes morpholines pyrazolopyrimidine tertiary amino compound Show first 5 Terms
has_role: angiogenesis inhibitor antineoplastic agent apoptosis inducer EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor vascular endothelial growth factor receptor antagonist

angiogenesis inhibitor antineoplastic agent apoptosis inducer EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor vascular endothelial growth factor receptor antagonist Show first 5 Terms

Phenotype

Phenotype resulting from DMH4

Phenotype where environments contain DMH4

Phenotype modified by environments containing DMH4

Human Disease Model